Documento fuente o registro público

FDA 510(k) K192073 — Helix Genetic Health Risk App for late-onset Alzheimer’s disease

FDA 510(k) index record K192073. Device: Helix Genetic Health Risk App for late-onset Alzheimer’s disease. Applicant as listed: Helix Opco, LLC. Decision date: 2020-12-23.

OtherU.S. Food and Drug Administration (FDA)2020-12-23

Fuente

"device_name": "Helix Genetic Health Risk App for late-onset Alzheimer’s disease"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K192073.

Device name: Helix Genetic Health Risk App for late-onset Alzheimer’s disease. Applicant as listed: Helix Opco, LLC.

Decision date: 2020-12-23. Decision wording: Substantially Equivalent.

Product code: PTA. Regulation: 21 CFR 866.5950. Medical specialty: Immunology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más